In this video, Professor Dr. Christoph Correll highlights the recent innovations in the pharmacological treatment of schizophrenia. He discusses both treatments that have recently been made available in some parts of the world and those currently under development in clinical trials.

Christoph Correll image

Prof. Christoph U Correll, MD.

The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA. Charité – Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.

Learn more about Schizophrenia
Published 17.04.2026
Permissions
Published 17.04.2026
Permissions

Related content

Can we help children at familial high-risk of schizophrenia? play_circle Video play_circle
Can we help children at familial high-risk of schizophrenia?

Professor Dr. Merete Nordentoft introduces her work with the population of children of parents with schizophrenia. She also highlights the model implemented in Denmark, called VIA family, and why it is important to focus on children of parents living with schizophrenia.

28.04.2026 Schizophrenia
Why is there a mortality gap in schizophrenia? play_circle Video play_circle
Why is there a mortality gap in schizophrenia?

Dr. Marco Solmi introduces what the mortality gap is and why there is a mortality gap in schizophrenia.

24.03.2026 Schizophrenia
description Article
Physical Health in Mental Disorders: Burden and Solutions

Physical health and mental disorders are closely linked, with mental–physical comorbidity posing a major global public health and equity challenge.

12.03.2026 Schizophrenia